P - (386) 672-1023   |   F - (386) 263-2996 


Dr. Lupercio

Florentino Lupercio  M.D., FACC, FHRS


Besides using catheter ablation to treat atrial fibrillation, Dr. Lupercio also has a special interest in stroke reduction in patients with AF using warfarin or newer blood thinners. His expertise also includes implantation and management of cardiac rhythm devices, including implantable loop recorders, leadless and standard pacemakers, cardiac defibrillators, and cardiac resynchronization therapy devices. Dr. Lupercio's research has resulted in publications in several top cardiology journals, including Journal of the American College of Cardiology and the Heart Rhythm Journal.


Specialties:

  • Cardiology
  • Electrophysiology

Board Certification:

  • Cardiovascular disease
  • Cardiac Electrophysiology
  • Internal Medicine

Languages:

  • English
  • Spanish

Medical School:

  • University of Guadalahara

Residency:

  • Jacobi Medical Center / Albert Einstein College of Medicine - Internal Medicine

Fellowships:

  • Montefiore Medical Center / Albert Einstein College of Medicine - Cardiology
  • University of California San Diego- Electrophysiology

Professional Interests:

  • Atrial Fibrillation
  • Complex Ablations
  • Ventricular Arrhythmias including PVCs
  • Supra-Ventricular Tachycardias (SVTs)
  • Cardiovascular Implantable Devices (Pacemakers, Defibrillators, CRT, Loop recorders)

Affiliated Organizations:

  • American College of Cardiology (FACC)
  • Heart Rhythm Society (HRS)
  • American Heart Association (AHA)

Publications:

  • Ablation of mitral annular flutter ablation utilizing a left atrial anterior line versus a lateral mitral isthmus line: a systematic review and meta-analysis
  • Early Versus Delayed Lead Extraction in Patients With Infected Cardiovascular Implantable Electronic Devices
  • Meta-analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction
  • Complete heart block and subsequent sudden cardiac death from immune checkpoint inhibitor-associated myocarditis
  • Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation
  • P2Y12 inhibitors in Combination with Oral Anticoagulation in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
  • Posterior Wall Isolation in Addition to Pulmonary Vein Isolation in Patients with Atrial Fibrillation - A Systematic Review and Meta-Analysis of Prospective Studies
  • Left Atrial Appendage Electrical Isolation as a Target in Atrial Fibrillation
  • Weight Loss in Management of Overweight and Obese Patients with Atrial Fibrillation
  • Is it safe to stop oral anticoagulation after catheter ablation for atrial fibrillation?
  • Current and Future Use of Insertable Cardiac Monitors, State of the Art Review
  • Clinical outcomes in patients with atrial fibrillation receiving amiodarone on NOACs vs. warfarin
  • Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials
  • Efficacy and Safety Outcomes of Direct Oral Anticoagulants and Amiodarone in Patients with Atrial Fibrillation.
  • Periprocedural Anticoagulation for Catheter Ablation of Atrial Fibrillation: Practical Implications for Perioperative Management
  • Myocardial Infarction after Endoscopic Removal of Foreign Body
  • Left Atrial Appendage Morphology Assessment for Risk Stratification of Embolic Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
  • Clinical Impact of Heparin Kinetics During Catheter Ablation of Atrial Fibrillation: Meta-Analysis and Meta-Regression
  • Where Is the Lead?: An Unusual Progression of Lead Fracture
  • 3-D Mapping Systems Compared to Conventional Mapping for Ablation Procedures
  • Microvascular Obstruction Detected by Cardiac MRI after AMI for the prediction of LV Remodeling and MACE: Microvascular Obstruction Detected by Cardiac MRI after AMI for the prediction of LV Remodeling and MACE: A Meta-Analysis of Prospective Trials
  • Addition of Angiotensin-Converting Enzyme Inhibitors to Beta-Blockers Has a Distinct Effect on Hispanics Compared to African-Americans and Whites with Heart Failure and Reduced Ejection Fraction: A Propensity Score Matching
  • Outcomes in patients with various forms of aortic stenosis including those with low-flow low-gradient normal and low ejection fraction
  • Myocardial Viability and Microvascular Obstruction (MVO): Role of Cardiac Magnetic Resonance Imaging

Personal Life:

  • Avid runner and sports fan
  • Enjoys Thai food
  • Loves spending time with his wife and two sons

Our Providers

Share by: